Kymera Therapeutics Inc (KYMR)

R&D Expenses

$375.60M

TTM · Period ending: · USD

KYMR logo

KYMR R&D Expenses

Latest reported$375.60M
KYMR R&D Expenses ($17.68M → $375.60M)
High-resolution chart · PNG

KYMR r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
316,600,000
240,248,000
189,081,000
164,248,000
137,017,000
62,105,000
37,158,000
17,679,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.